Abstract |
|
Authors | Eric Deconinck, Charles Foussard, Noel Milpied, Philippe Bertrand, Patrick Michenet, Pascale Cornillet-LeFebvre, Martine Escoffre-Barbe, Herve Maisonneuve, Vincent Delwail, Remy Gressin, Eric Legouffe, Jean-Pierre Vilque, Bernard Desablens, Jerome Jaubert, Jean-François Ramee, Arash Jenabian, Antoine Thyss, Annick Le Pourhiet-Le Mevel, Philippe Travade, Roselyne Delepine, Philippe Colombat, GOELAMS |
Journal | Blood
(Blood)
Vol. 105
Issue 10
Pg. 3817-23
(May 15 2005)
ISSN: 0006-4971 [Print] United States |
PMID | 15687232
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adult
- Disease Progression
- Doxorubicin
(adverse effects, therapeutic use)
- Feasibility Studies
- Female
- Follow-Up Studies
- France
- Humans
- Lymphoma, Follicular
(drug therapy, pathology, surgery, therapy)
- Male
- Middle Aged
- Neoplasm Staging
- Recurrence
- Stem Cell Transplantation
- Survival Rate
- Transplantation, Autologous
|